Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark O Hardin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diseases of the Colon and Rectum|December 10, 2015
Fluorescence Angiography in Colorectal ResectionEric K Johnson, Mark O Hardin, Avery S Walker, et al.
Military Medicine|January 10, 2014
Plasma-to-red cell ratio and mechanism of injury in massively transfused combat casualtiesMark O Hardin, John D Ritchie, James K Aden, et al.
The Journal of Trauma|July 29, 2011
Mechanism of injury affects acute coagulopathy of trauma in combat casualtiesJohn W Simmons, Christopher E White, John D Ritchie, et al.
Burns : Journal of the International Society for Burn Injuries|June 3, 2014
Mucormycosis attributed mortality: a seven-year review of surgical and medical managementThomas A Mitchell, Mark O Hardin, Clinton K Murray, et al.
Burns : Journal of the International Society for Burn Injuries|September 10, 2013
Outcomes after cardiac arrest in an adult burn centerJonathan C Wilton, Mark O Hardin, John D Ritchie, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 11, 2012
An experience in the management of the open abdomen in severely injured burn patientsMark O Hardin, James E Mace, John D Ritchie, et al.
BMC Anesthesiology|June 26, 2010
Fenoldopam use in a burn intensive care unit: a retrospective studyJohn W Simmons, Kevin K Chung, Evan M Renz, et al.
Cancer Immunology, Immunotherapy : CII|February 20, 2016
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2Julia M Greene, Erika J Schneble, Doreen O Jackson, et al.
Immunotherapy|February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccineMark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.
Vaccine|May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumorsGarth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diseases of the Colon and Rectum|December 10, 2015
Fluorescence Angiography in Colorectal ResectionEric K Johnson, Mark O Hardin, Avery S Walker, et al.
Military Medicine|January 10, 2014
Plasma-to-red cell ratio and mechanism of injury in massively transfused combat casualtiesMark O Hardin, John D Ritchie, James K Aden, et al.
The Journal of Trauma|July 29, 2011
Mechanism of injury affects acute coagulopathy of trauma in combat casualtiesJohn W Simmons, Christopher E White, John D Ritchie, et al.
Burns : Journal of the International Society for Burn Injuries|June 3, 2014
Mucormycosis attributed mortality: a seven-year review of surgical and medical managementThomas A Mitchell, Mark O Hardin, Clinton K Murray, et al.
Burns : Journal of the International Society for Burn Injuries|September 10, 2013
Outcomes after cardiac arrest in an adult burn centerJonathan C Wilton, Mark O Hardin, John D Ritchie, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 11, 2012
An experience in the management of the open abdomen in severely injured burn patientsMark O Hardin, James E Mace, John D Ritchie, et al.
BMC Anesthesiology|June 26, 2010
Fenoldopam use in a burn intensive care unit: a retrospective studyJohn W Simmons, Kevin K Chung, Evan M Renz, et al.
Cancer Immunology, Immunotherapy : CII|February 20, 2016
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2Julia M Greene, Erika J Schneble, Doreen O Jackson, et al.
Immunotherapy|February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccineMark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.
Vaccine|May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumorsGarth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.
Pageof 2